GSA Capital Partners LLP Has $1.13 Million Stock Holdings in Phreesia, Inc. (NYSE:PHR)

GSA Capital Partners LLP lifted its stake in shares of Phreesia, Inc. (NYSE:PHR) by 418.3% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 49,553 shares of the company’s stock after acquiring an additional 39,993 shares during the period. GSA Capital Partners LLP’s holdings in Phreesia were worth $1,129,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in PHR. Champlain Investment Partners LLC acquired a new position in shares of Phreesia in the first quarter valued at $29,941,000. Boston Partners acquired a new position in shares of Phreesia during the 1st quarter worth about $669,000. Russell Investments Group Ltd. raised its holdings in Phreesia by 1,407.9% in the first quarter. Russell Investments Group Ltd. now owns 57,874 shares of the company’s stock worth $1,385,000 after purchasing an additional 54,036 shares during the period. Blair William & Co. IL lifted its holdings in Phreesia by 42.6% during the first quarter. Blair William & Co. IL now owns 752,700 shares of the company’s stock worth $18,012,000 after acquiring an additional 224,950 shares in the last quarter. Finally, Sei Investments Co. increased its stake in Phreesia by 135.3% during the 2nd quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock worth $3,505,000 after purchasing an additional 95,058 shares in the last quarter. Institutional investors own 92.10% of the company’s stock.

Phreesia Stock Down 6.1 %

PHR stock opened at $20.99 on Friday. Phreesia, Inc. has a twelve month low of $14.55 and a twelve month high of $29.16. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.03. The firm has a market capitalization of $1.21 billion, a PE ratio of -12.09 and a beta of 0.94. The stock has a 50-day simple moving average of $21.49 and a two-hundred day simple moving average of $22.04.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Wednesday, September 4th. The company reported ($0.31) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.37) by $0.06. The company had revenue of $102.12 million during the quarter, compared to analysts’ expectations of $101.76 million. Phreesia had a negative net margin of 25.73% and a negative return on equity of 39.34%. On average, equities analysts predict that Phreesia, Inc. will post -1.23 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms have recently weighed in on PHR. Robert W. Baird upped their price objective on Phreesia from $31.00 to $34.00 and gave the stock an “outperform” rating in a research report on Friday, September 6th. JPMorgan Chase & Co. raised their price objective on Phreesia from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Monday, September 9th. JMP Securities reiterated a “market outperform” rating and issued a $30.00 price target on shares of Phreesia in a research note on Thursday, September 5th. Truist Financial upped their price target on shares of Phreesia from $29.00 to $31.00 and gave the company a “buy” rating in a research note on Friday, September 6th. Finally, DA Davidson restated a “buy” rating and set a $32.00 price objective on shares of Phreesia in a research note on Thursday, September 5th. One equities research analyst has rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $29.42.

Insider Buying and Selling at Phreesia

In related news, CEO Chaim Indig sold 5,295 shares of the company’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $23.25, for a total value of $123,108.75. Following the transaction, the chief executive officer now directly owns 1,223,736 shares of the company’s stock, valued at approximately $28,451,862. This represents a 0.43 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, General Counsel Allison C. Hoffman sold 1,212 shares of the business’s stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $21.03, for a total value of $25,488.36. Following the completion of the transaction, the general counsel now directly owns 119,791 shares of the company’s stock, valued at approximately $2,519,204.73. This trade represents a 1.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 44,107 shares of company stock valued at $1,035,226. 5.80% of the stock is currently owned by company insiders.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.